Evolution of enterobacteriaceae resistance to antibiotics in Reunion Island: Emergence of extended spectrum beta-lactamases;Évolution de la résistance des entérobactéries aux antibiotiques sur l'île de la Réunion: émergence des bêta-lactamases à spectre élargi

Pathologie Biologie

Volumn 58, Issue 1, 2010, Pages 18-24

  Belmonte, O ^a   Drouet, D ^a   Alba, J ^b   Moiton, M P ^a   Kuli, B ^a   Lugagne Delpon, N ^a   Mourlan, C ^c   Jaffar Bandjee, M C ^a  

^a Centre hospitalier regional de La Reunion   (France)

^b Pharmacie Centre hospitalier régional de La Réunion   (France)

^c Centre hospitalier régional de La Réunion   (France)

Author keywords

Antibiotics consumption; Enterobacteriaceae; Extended spectrum betalactamase; Multidrug resistance; Reunion Island

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; CEPHALOSPORINASE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRESCRIPTION; PREVALENCE; REUNION; RISK ASSESSMENT; CROSS INFECTION; DRUG EFFECT; DRUG UTILIZATION; ENTEROBACTERIACEAE INFECTION; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; RETROSPECTIVE STUDY;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINASE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FLUOROQUINOLONES; HUMANS; IMIPENEM; RETROSPECTIVE STUDIES; REUNION; SUBSTRATE SPECIFICITY;

EID: 77349121372     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.07.021     Document Type: Article

References (23)

1. Coque T., Baquerot F., Canton R. Increasing prevalence of ESBL - producing Enterobacteriaceae in Europe. Eurosurveillance 2008, 13(47):1-11.
2. Lavollay M., Mamlouk K., Frank T., Akapabie A., Burghoffer B., Ben Redjeb S., et al. Clonal dissemination of CTX-M-15 betalactamase-producing Escherichia coli strain in the Paris Area, Tunis and Bangui. Antimicrob. Agents Chemother. 2006, 50(7):2433-2438.
3. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX M-15. J Antimicrob Chemother 2008, 61:273-281.
4. Pitout J.D., Laupland K. Extended spectrum betalactamase-producing Enterobacteriacaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166.
5. Pitout J.D., Nordmann P., Laupland K. Poirel. Emergence of Eneterobacteriaceae producing extended spectrum betalacatamases (ESBL) in the community. J Antimicrob Chemother 2005, 56:52-59.
6. Schwaber M.J., Navon-Venezia S., Kaye K., Ben-Ami R., Schwartz D., Carmali Y. Clinical and economic impact of bacteremia with extended spectrum betalactamase-producing in Enterobacteriaceae. Antimicrob Agents Chemother 2006, 50(4):1257-1262.
7. Société française d'hygiène hospitalière. Prévention de la transmission croisée: préventions complémentaires contact. Recommandations nationales: 2009; vol XVII-no 2:83-126.
8. Garau J. Other antimicrobials of interest in the era of extended spectrum betalactamases: fosfomycine, nitrofurantoin and tigecyclin. Clin Microbiol Infect 2008, 14(Suppl. 1):198-202.
9. Van de Sande-Bruinsma N., Grundmann H., Verloo D., Tiemersma E., Monen J., Grossens H., et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008, 14(11):1722-1730.
10. Belmonte O, Moiton MP, Drouet D, Lefort Y, Alba J, Jaffar-Bandjee MC. Particularité de l'écologie bactérienne réunionnaise: actualité au centre hospitalier Félix Guyon (CHFG)...[résumé] 28e réunion interdisciplinaire de chimiothérapie anti-infectieuse. 2008 Dec 4-5; Paris (France);p178.
11. Oteo J., Delgado-Iribarren A., Vega D., Bautista V., Cruz Rodriguez M., Velasco M., et al. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int J Antimicrob Agents 2008, 32(6):534-537.
12. Pillai D., Melano R., Lo S., Tijet N., Fuksa M., Roda N. Klebsiella pneumoniae, Carbapenemase, Canada. Emerg Infect Dis 2009, 15(5):827-829.
13. Randrianirina F., Vedy S., Rakotovao D., Ramarokoto C., Ratsitohaina H., Carod J.F., et al. Role of contaminated aspirations tubes in nosocomial outbreak of Klebsiella penumoniae producing SHV-2 and CTX-M-15 extended spectrum betalactamases. J Hosp Infect 2009, 72(1):23-29.
14. Randrianirina F., Soares J.L., Carod J.F., Ratsima E., Thonnier V., Combe P., et al. Antimicorbial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother 2007, 59:309-312.
15. Laupland K., Church D., Vidakovich J., Mucenski M., Pitout J. Community-onset extended spectrum betalactamase (ESBL) producing Escherichia coli: Importance of international travel. international travel. J Infect 2008, 57(6):441-448.
16. Hawkey P.M. Prevalence and clonality of extended spectrum betalactamase in Asia. Clin Microbiol Infect 2008, 14(Suppl.1):159-165.
17. Brink A., MoolmanJ, da Silva M.C., Botha M. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S Afr Med J 2007, 97(4):273-279.
18. Cotton M.F., Wasserman E., Smit J., Whitelaw A., Zar H.J. High incidence of antimicrobial resistant organisms including extended spectrum betalactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town. South Africa. BMC Infect Dis 2008, 1(8):40.
19. Tellevik M.G., Sollid J.E., Blomberg B., Jureen R., Urassa W.K., Langeland N. Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: vectors for horizontal transfer of antimicrobial resistance. Diagn Microbiol Infect Dis 2007, 59(3):351-354.
20. Giraud-Morin C., Fosse T. Évolution récente et caractérisation des entérobactéries productrices de BLSE au CHU de Nice. Pathol Biol 2008, 56(7-8):417-423.
21. Carattoli A. Animal reservoirs for extended spectrum betalactamase producers. Clin Microbiol Infect 2008, 14(suppl. 1):117-123.
22. Ruppé E., Hem S., Lath S., Gautier V., Ariey F., Sarthou J.L., et al. CTX-M betalactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis 2009, 15(5):741-748.
23. Warren R.E., Harvey G., Carr R., Ward D., Doroshenko A. Control of infections due to extended spectrum betalactamase-producing organisms in hospitals and the community. Clin Microbiol Infect 2008, 14(Suppl.1):124-133.